JPH07500605A - 三置換テトラヒドロフラン抗真菌化合物 - Google Patents
三置換テトラヒドロフラン抗真菌化合物Info
- Publication number
- JPH07500605A JPH07500605A JP5508464A JP50846493A JPH07500605A JP H07500605 A JPH07500605 A JP H07500605A JP 5508464 A JP5508464 A JP 5508464A JP 50846493 A JP50846493 A JP 50846493A JP H07500605 A JPH07500605 A JP H07500605A
- Authority
- JP
- Japan
- Prior art keywords
- formulas
- tables
- compound
- carbon atoms
- chemical formulas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (10)
- 1.式[I]: ▲数式、化学式、表等があります▼[I](上式において、Xは、2つともFで あるか、2つともC1であるか、一方がFでもう一方がC1であり、 Yは、 ▲数式、化学式、表等があります▼;▲数式、化学式、表等があります▼;▲数 式、化学式、表等があります▼;▲数式、化学式、表等があります▼;▲数式、 化学式、表等があります▼;▲数式、化学式、表等があります▼;▲数式、化学 式、表等があります▼ であり、 R′は、炭素数1−10のアルキル、炭素数2−10のアルケニル、炭素数2− 10のアルキニル、炭素数3−8のシクロアルキルまたはCH2R2であり、R 2は、炭素数1−3の過ハロアルキル、CO2R3、*CH(OR4)CH2O R4またはCH2N(R5)であり、 R3は、低級アルキルまたはHであり、R4は、R3または(CH2)2OR3 であり、R5は、低級アルキルであり、 Zは、Hまたは炭素数1−5のアルカノイルであり、アステリスク(*)が付い ている炭素原子はRまたはSの絶対配置を有する)で表される化合物またはその 薬学的に許容される塩。
- 2.式[Ia] ▲数式、化学式、表等があります▼[Ia](上式において、Xは、2つともF であるか、2つともClであるか、一方がFでもう一方がClであり、 R′は、 ▲数式、化学式、表等があります▼,▲数式、化学式、表等があります▼,▲数 式、化学式、表等があります▼▲数式、化学式、表等があります▼,▲数式、化 学式、表等があります▼,▲数式、化学式、表等があります▼−CH2CO2H ,−CH2CH2N(CH3)2,−(CH2)4C=CH−CH2CH=CH C2H5,▲数式、化学式、表等があります▼−CH2−C≡C−CH3,▲数 式、化学式、表等があります▼▲数式、化学式、表等があります▼,▲数式、化 学式、表等があります▼,−(CH2)CH=C(CH3)2,−CH2CH= CHCH(CH3)3−CH2−■CH(OH)CH2OH であり、 アステリスク(*)か付いている炭素原子はRまたはSの絶対配置を有する)で 表される化合物またはその藥学的に許容される塩。
- 3.式II: ▲数式、化学式、表等があります▼(II)(上式において、アステリスク(* )が付いている炭素原子はRまたはSの絶対配置を有する) で表される化合物およびその立体異性体またはその薬学的に許容される塩。
- 4.式IIa: ▲数式、化学式、表等があります▼IIaで表される(一)−[(5R)−シス ]−4−[4−[4−[4−[[5−(2,4−ジフルオロフェニル)−5−( 1H−1,2,4−トリアゾール−1−イルメチル)テトラヒドロフラン−3− イル]メトキシ]フェニル]−1−ピペラジニル]フェニル]−2,4−ジヒド ロ−2−[(R)−(1−メチルプロピル)]−3H−1,2,4−トリアゾー ル−3−オン、式IIb: ▲数式、化学式、表等があります▼IIbで表される(一)−[(5R)−シス ]−4−[4−[4−[4−[[5−(2,4−ジフルオロフェニル)−5−( 1H−1,2,4−トリアゾール−1−イルメチル)テトラヒドロフラン−3− イル]メトキシ]フェニル]−1−ピペラジニル]フェニル]−2,4−ジヒド ロ−2−[(S)−(1−メチルプロピル)]−3H−1,2,4−トリアゾー ル−3−オン、または、式IIc ▲数式、化学式、表等があります▼IIcで表される(一)−[(5R)−シス ]−4−[4−[4−[4−[[5−(2,4−ジフルオロフェニル)−5−( 1H−1,2,4−トリアゾール−1−イルメチル)テトラヒドロフラン−3− イル]メトキシ]フェニル]−1−ピペラジニル]フェニル]−2,4−ジヒド ロ−2−(3−ペンチル)−3H−1,2,4−トリアゾール−3−オンである 請求項3の化合物。
- 5.抗真菌効果量の請求項1の化合物および薬学的に許容される担体からなる真 菌感染治療剤。
- 6.担体がヒドロキシプロピル−α−,β−またはγ−シクロデキストリンであ る請求項5の治療剤。
- 7.1分子あたり約2から約11のヒドロキシプロピル基を有するヒドロキシプ ロピル−β−シクロデキストリンをさらに含有する請求項5の治療剤。
- 8.抗真菌効果量の細胞壁活性化合物からなる請求項5の治療剤。
- 9.真菌感染の予防または治療が必要な哺乳動物に、抗真菌効果量の請求項1の 化合物を投与することからなる真菌感染予防および治療法。
- 10.式III、IV、VまたはVI:▲数式、化学式、表等があります▼II I▲数式、化学式、表等があります▼VII▲数式、化学式、表等があります▼ IV▲数式、化学式、表等があります▼V ▲数式、化学式、表等があります▼ (上式において、Xは、2つともFであるか、2つともClであるか、一方がF でもう一方がClであり、 R′は、炭素数1−10のアルキル、炭素数2−10のアルケニル、炭素数2− 10のアルキニル、炭素数3−8のシクロアルキルまたはCH2R2であり、R 2は、炭素数1−3の過ハロアルキル、CO2R3、*CH(OR4)CH2O R4またはCH2N(R5)であり、 R3は、低級アルキルまたはHであり、R4は、R3または(CH2)2OR3 であり、R5は、低級アルキルであり、 Zは、OHまたはLGであり、 LGは、脱離基であり、 R′は、低級アルキルまたはZであり、Zは、Hまたは炭素数1−5のアルカノ イルであり、アステリスク(*)が付いている炭素原子はRまたはSの絶対配置 を有する)で表される化合物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78535791A | 1991-10-30 | 1991-10-30 | |
US785,357 | 1991-10-30 | ||
US90726292A | 1992-07-01 | 1992-07-01 | |
US907,262 | 1992-07-01 | ||
PCT/US1992/008981 WO1993009114A1 (en) | 1991-10-30 | 1992-10-28 | Tri-substituted tetrahydrofuran antifungals |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07500605A true JPH07500605A (ja) | 1995-01-19 |
JP3210017B2 JP3210017B2 (ja) | 2001-09-17 |
Family
ID=27120397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50846493A Expired - Fee Related JP3210017B2 (ja) | 1991-10-30 | 1992-10-28 | 三置換テトラヒドロフラン抗真菌化合物 |
Country Status (22)
Country | Link |
---|---|
EP (2) | EP0539938A1 (ja) |
JP (1) | JP3210017B2 (ja) |
CN (1) | CN1037267C (ja) |
AT (1) | ATE198888T1 (ja) |
AU (1) | AU665218B2 (ja) |
CA (1) | CA2122270C (ja) |
CZ (1) | CZ102794A3 (ja) |
DE (1) | DE69231661T2 (ja) |
ES (1) | ES2153364T3 (ja) |
FI (1) | FI941986A (ja) |
HR (1) | HRP921145A2 (ja) |
HU (1) | HUT70742A (ja) |
IL (1) | IL103558A0 (ja) |
MX (1) | MX9206222A (ja) |
MY (1) | MY109529A (ja) |
NO (1) | NO941589L (ja) |
NZ (1) | NZ244910A (ja) |
SG (1) | SG42920A1 (ja) |
SI (1) | SI9200285A (ja) |
SK (1) | SK48894A3 (ja) |
WO (1) | WO1993009114A1 (ja) |
YU (1) | YU94792A (ja) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5403937A (en) * | 1993-04-30 | 1995-04-04 | Schering Corporation | Process for preparing intermediates for the synthesis of antifungal agents |
US5349099A (en) * | 1993-12-13 | 1994-09-20 | Schering Corporation | Process for preparing intermediates for the synthesis of antifungal agents |
US5703236A (en) * | 1993-12-21 | 1997-12-30 | Schering Corporation | Tetrahydrofuran antifungals |
US5693626A (en) * | 1993-12-21 | 1997-12-02 | Schering Corporation | Tetrahydrofuran antifungals |
US5703079A (en) * | 1993-12-21 | 1997-12-30 | Schering Corporation | Tetrahydrofuran antifungals |
CO4520281A1 (es) * | 1993-12-21 | 1997-10-15 | Schering Corp | Antifungicos de tetrahidrofurano |
US5710154A (en) * | 1993-12-21 | 1998-01-20 | Schering Corporation | Tetrahydrofuran antifungals |
US5714490A (en) * | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
US5661151A (en) * | 1993-12-21 | 1997-08-26 | Schering Corporation | Tetrahydrofuran antifungals |
ATE186540T1 (de) * | 1994-01-24 | 1999-11-15 | Janssen Pharmaceutica Nv | Wasserlösliche azol-antifungus |
JP3828147B2 (ja) * | 1994-04-19 | 2006-10-04 | 株式会社カネカ | トリアゾール誘導体の製造法 |
US5442093A (en) * | 1994-05-09 | 1995-08-15 | Schering Corporation | Process for preparing intermediates for the synthesis of antifungal agents |
US5486625A (en) * | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
US5702928A (en) * | 1994-07-18 | 1997-12-30 | Daicel Chemical Industries, Ltd. | Process for producing optically active triazole compounds and method of racemizing optically active triazole compounds |
US5625064A (en) * | 1995-04-19 | 1997-04-29 | Schering Corporation | Process for the preparation of triazolones |
US5616777A (en) * | 1995-04-19 | 1997-04-01 | Schering Corporation | Chiral hydrazine derivatives |
ES2199291T3 (es) * | 1995-06-02 | 2004-02-16 | Schering Corporation | Antifungicos de tetrahidrofurano. |
ES2203707T3 (es) * | 1995-06-19 | 2004-04-16 | Schering Corporation | Antifungicos de tetrahidrofurano. |
US5698557A (en) * | 1995-06-19 | 1997-12-16 | Schering Corporation | Hydroxy-substituted antifungals |
US5834472A (en) * | 1996-05-24 | 1998-11-10 | Schering Corporation | Antifungal composition with enhanced bioavailability |
US5846971A (en) * | 1996-06-28 | 1998-12-08 | Schering Corporation | Oral antifungal composition |
TW593312B (en) | 1997-07-11 | 2004-06-21 | Janssen Pharmaceutica Nv | 2,4,4-trisubstituted-1,3-dioxolane antifungals |
SK285190B6 (sk) * | 1997-10-07 | 2006-08-03 | Schering Corporation | Kryštálová modifikácia proti plesniam a farmaceutický prostriedok s jej obsahom |
CN1628119A (zh) * | 2002-04-12 | 2005-06-15 | 兰贝克赛实验室有限公司 | 作为抗真菌剂的2,2,4-三取代的四氢呋喃衍生物 |
AU2011254654B2 (en) | 2010-05-19 | 2016-01-07 | Sandoz Ag | Process for the preparation of chiral triazolones |
CA2798007C (en) | 2010-05-19 | 2018-10-23 | Sandoz Ag | Preparation of posaconazole intermediates |
WO2011144657A1 (en) | 2010-05-19 | 2011-11-24 | Sandoz Ag | Purification of posaconazole and posaconazole intermediates |
EP2571847B1 (en) | 2010-05-19 | 2016-09-21 | Sandoz AG | Process for the preparation of chiral hydrazides |
WO2012172015A1 (en) | 2011-06-16 | 2012-12-20 | Sandoz Ag | Process for the preparation of a chiral compound |
JP6414831B2 (ja) * | 2013-06-07 | 2018-10-31 | ザ カリフォルニア インスティテュート フォー バイオメディカル リサーチ | 繊維症の小分子阻害剤 |
CN106397417A (zh) * | 2016-08-30 | 2017-02-15 | 甘肃皓天化学科技有限公司 | 用于制备泊沙康唑的中间体的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02504033A (ja) * | 1987-11-20 | 1990-11-22 | シェリング・コーポレーション | トリ‐およびテトラ‐置換‐オキセタンおよびテトラヒドロフランおよびその中間体 |
US5039676A (en) * | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4267179A (en) * | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
DE3346123A1 (de) | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
DK354185A (da) * | 1984-08-31 | 1986-03-01 | Hoffmann La Roche | 1,3-dioxolanderivater |
NZ223799A (en) * | 1987-03-25 | 1989-12-21 | Janssen Pharmaceutica Nv | Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions |
US5006513A (en) | 1987-11-09 | 1991-04-09 | Miles Inc. | Antimycotic compositions of nikkomycin compounds and azole antimycotica |
US5002935A (en) | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
NZ233502A (en) * | 1989-06-09 | 1991-11-26 | Janssen Pharmaceutica Nv | 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions |
US20040220100A1 (en) | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
-
1992
- 1992-10-27 IL IL103558A patent/IL103558A0/xx unknown
- 1992-10-28 AT AT92923060T patent/ATE198888T1/de active
- 1992-10-28 EP EP92118413A patent/EP0539938A1/en active Pending
- 1992-10-28 ES ES92923060T patent/ES2153364T3/es not_active Expired - Lifetime
- 1992-10-28 CZ CZ941027A patent/CZ102794A3/cs unknown
- 1992-10-28 SK SK488-94A patent/SK48894A3/sk unknown
- 1992-10-28 MX MX9206222A patent/MX9206222A/es unknown
- 1992-10-28 CA CA002122270A patent/CA2122270C/en not_active Expired - Lifetime
- 1992-10-28 SG SG1996000735A patent/SG42920A1/en unknown
- 1992-10-28 JP JP50846493A patent/JP3210017B2/ja not_active Expired - Fee Related
- 1992-10-28 HU HU9401256A patent/HUT70742A/hu unknown
- 1992-10-28 EP EP92923060A patent/EP0610377B1/en not_active Expired - Lifetime
- 1992-10-28 NZ NZ244910A patent/NZ244910A/en unknown
- 1992-10-28 AU AU29169/92A patent/AU665218B2/en not_active Ceased
- 1992-10-28 WO PCT/US1992/008981 patent/WO1993009114A1/en active IP Right Grant
- 1992-10-28 MY MYPI92001943A patent/MY109529A/en unknown
- 1992-10-28 DE DE69231661T patent/DE69231661T2/de not_active Expired - Lifetime
- 1992-10-29 SI SI19929200285A patent/SI9200285A/sl unknown
- 1992-10-29 HR HR921145A patent/HRP921145A2/hr not_active Application Discontinuation
- 1992-10-29 YU YU94792A patent/YU94792A/sh unknown
- 1992-10-29 CN CN92113399A patent/CN1037267C/zh not_active Expired - Fee Related
-
1994
- 1994-04-29 NO NO941589A patent/NO941589L/no unknown
- 1994-04-29 FI FI941986A patent/FI941986A/fi not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02504033A (ja) * | 1987-11-20 | 1990-11-22 | シェリング・コーポレーション | トリ‐およびテトラ‐置換‐オキセタンおよびテトラヒドロフランおよびその中間体 |
US5039676A (en) * | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
Also Published As
Publication number | Publication date |
---|---|
YU94792A (sh) | 1995-12-04 |
CN1073944A (zh) | 1993-07-07 |
EP0539938A1 (en) | 1993-05-05 |
CA2122270C (en) | 2006-05-23 |
NO941589L (ja) | 1994-06-23 |
MX9206222A (es) | 1993-04-01 |
FI941986A0 (fi) | 1994-04-29 |
EP0610377A1 (en) | 1994-08-17 |
HUT70742A (en) | 1995-10-30 |
FI941986A (fi) | 1994-04-29 |
HRP921145A2 (en) | 1994-08-31 |
CZ102794A3 (en) | 1995-03-15 |
CA2122270A1 (en) | 1993-05-13 |
AU2916992A (en) | 1993-06-07 |
AU665218B2 (en) | 1995-12-21 |
JP3210017B2 (ja) | 2001-09-17 |
NO941589D0 (ja) | 1994-04-29 |
IL103558A0 (en) | 1993-03-15 |
SI9200285A (en) | 1993-06-30 |
EP0610377B1 (en) | 2001-01-24 |
SG42920A1 (en) | 1997-10-17 |
ATE198888T1 (de) | 2001-02-15 |
DE69231661T2 (de) | 2001-08-02 |
WO1993009114A1 (en) | 1993-05-13 |
CN1037267C (zh) | 1998-02-04 |
MY109529A (en) | 1997-02-28 |
ES2153364T3 (es) | 2001-03-01 |
DE69231661D1 (de) | 2001-03-01 |
NZ244910A (en) | 1996-01-26 |
SK48894A3 (en) | 1995-02-08 |
HU9401256D0 (en) | 1994-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07500605A (ja) | 三置換テトラヒドロフラン抗真菌化合物 | |
DE69628117T2 (de) | Antifungale tetrahydrofurane | |
JP2834889B2 (ja) | テトラヒドロフラン抗真菌剤 | |
WO1999045008A1 (en) | 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity | |
IE55233B1 (en) | Triazole antifungal agents | |
HU211515A9 (en) | Optically active triazole derivatives and compositions | |
JPH0436153B2 (ja) | ||
HU195502B (en) | Process for producing triazol derivatives of fungicide activity and pharmaceutical compositions containing them | |
HU189632B (en) | Process for producing triazilyl-alkanols and pharmaceutical compositions containing them as active agents | |
JPS6084284A (ja) | 抗真菌性トリアゾ−ル誘導体 | |
US6710049B2 (en) | Azole compounds as anti-fungal agents | |
JP3473949B2 (ja) | 対応する抗真菌剤のためのプロドラッグとしてのテトラヒドロフランリン酸エステルおよびヒドロキシエステル | |
HU193615B (en) | Process for production of derivatives of optically active asolile-carbinol and medical compounds containing thereof | |
JPH01102066A (ja) | 抗糸状菌剤 | |
WO1997000248A1 (en) | Hydroxyalkyl-substituted triazolones antifungals | |
US20040242896A1 (en) | Azole compounds as anti-fungal agents | |
JPH01151564A (ja) | 3−(4−クロロフエニル)−2,2−ジメチル−3−ヒドロキシ−4−(1,2,4−トリアゾル−1−イル)ブチロニトリル | |
US5698557A (en) | Hydroxy-substituted antifungals | |
JPH10231296A (ja) | テトラヒドロフラン抗真菌剤 | |
KR19980073433A (ko) | 테트라하이드로푸란 항진균제 | |
PL170743B1 (pl) | Sposób wytwarzania trójpodstawionego tetrahydrofuranowego związku | |
CZ20001008A3 (cs) | Tetrahydrofuranová sloučenina a farmaceutický prostředek ji obsahující | |
JPH08104680A (ja) | 2−アリール−1−(1h−1,2,4−トリアゾー ル−1−イル)ブタン−2−オール誘導体 | |
AU2002217365A1 (en) | Azole compounds as anti-fungals agents | |
WO1999018111A1 (en) | Crystalline antifungal glycine ester polymorph |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070713 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080713 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080713 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090713 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100713 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100713 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110713 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |